Stoke Therapeutics Inc buy Chardan Capital
Start price
19.02.25
/
50%
€8.95
Target price
19.02.26
€23.00
Performance (%)
174.86%
Price
20.01.26
€24.60
Summary
This prediction is currently active. The BUY prediction by Chardan_Capital for Stoke Therapeutics Inc has seen massive gains of 174.86%. This prediction currently runs until 19.02.26. The prediction end date can be changed by Chardan_Capital at any time. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Stoke Therapeutics Inc | -6.107% | -6.107% |
| iShares Core DAX® | -3.141% | 1.269% |
| iShares Nasdaq 100 | -3.518% | -1.355% |
| iShares Nikkei 225® | -3.396% | 3.283% |
| iShares S&P 500 | -2.943% | -0.533% |
Comments by Chardan_Capital for this prediction
In the thread Stoke Therapeutics Inc diskutieren
Stoke Therapeutics, Inc. (NASDAQ: STOK) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $24.00 price target on the stock.
Ratings data for STOK provided by MarketBeat
Stopped prediction by Chardan_Capital for Stoke Therapeutics Inc
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€25.80
05.01.26
05.01.26
€29.93
05.01.27
05.01.27
-4.65%
20.01.26
20.01.26
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€13.80
13.08.25
13.08.25
€20.55
13.08.26
13.08.26
78.26%
20.01.26
20.01.26
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€10.70
20.12.24
20.12.24
€23.06
20.12.25
20.12.25
152.34%
21.12.25
21.12.25